We sit at the start of an R&D revolution.

Drug development is undergoing significant change to permanently re-shape its activities, with moves away from large budgets and research teams towards external resources. Because pricing pressures from patients, governments and insurance companies and rising cost hurdles to registering products, the drive to produce more effective, safer drugs, more cleverly and at lower development cost with less risk will continue.

Choose your knowledge partners with care!!